T4 breast cancer under closer inspection: A case for revision of the TNM classification

Breast

Volumn 16, Issue 6, 2007, Pages 625-636

  Güth, Uwe ^a   Jane Huang, Dorothy ^a   Holzgreve, Wolfgang ^a   Wight, Edward ^a   Singer, Gad ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Breast cancer; Prognosis; Skin involvement; TNM classification

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; HISTOPATHOLOGY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SKIN EDEMA; SKIN TUMOR; SKIN ULCER; THORAX WALL TUMOR; TUMOR VOLUME;

EID: 36448990848     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.05.006     Document Type: Article

References (61)

1. Sugg S., and Donegan W. Staging and prognosis. In: Donegan W., and Spratt J. (Eds). Cancer of the breast. 5th ed (2002), W.B. Saunders, Philadelphia 477-506
2. Greene F., Page D., Fleming I., Fritz A., Balch C., Haller D., et al. AJCC cancer staging manual. 6th ed (2002), Springer, New York
3. In: Sobin L., and Wittekind C. (Eds). TNM classification of malignant tumors. 6th ed (2002), Wiley, New York
4. Haagensen C., and Stout A. Carcinoma of the breast: criteria of inoperability. Am Surg 118 (1943) 859-866
5. Haagensen C. Clinical classification of the stage of advancement of breast carcinoma diseases of the breast. 3rd ed (1986), W.B. Saunders, Philadelphia p. 851-63
6. Anderson W.F., Chu K.C., and Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities. J Clin Oncol 21 12 (2003) 2254-2259. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=12805323 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=12805323〉
7. Buchholz T.A., Strom E.A., Oswald M.J., Perkins G.H., Oh J., Domain D., et al. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 65 4 (2006) 1155-1160. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16750325 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16750325〉
8. Dirix L.Y., Dam P.V., Prove A., and Vermeulen P.B. Inflammatory breast cancer: current understanding. Curr Opin Oncol 18 6 (2006) 563-571. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16988576 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16988576〉
9. Le M.G., Arriagada R., Contesso G., Cammoun M., Pfeiffer F., Tabbane F., et al. Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients. Clin Breast Cancer 6 5 (2005) 439-445. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16381628 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16381628〉
10. Lerouge D., Touboul E., Lefranc J.P., Genestie C., Moureau-Zabotto L., and Blondon J. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Int J Radiat Oncol Biol Phys 59 4 (2004) 1062-1073. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&op t=Citation&list_uids=15234040 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15234040〉
11. Swain S.M. Locally advanced noninflammatory breast cancer. Cancer Invest 17 3 (1999) 211-219. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=10099661 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=10099661〉
12. Van der Auwera I., Van Laere S.J., Van den Eynden G.G., Benoy I., van Dam P., Colpaert C.G., et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 10 23 (2004) 7965-7971. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15585631 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15585631〉
13. In: Wittekind C., Henson D.E., Hutter R.V.P., and Sobin L.H. (Eds). TNM supplement. A commentary on uniform use. 2nd ed (2001), Wiley-Liss, New York
14. In: Wittekind C., Greene F.L., Henson D.E., Hutter R.V.P., and Sobin L.H. (Eds). TNM supplement. A commentary on uniform use. 3rd ed (2004), Wiley-Liss, New York
15. Guth U., Moch H., Herberich L., and Holzgreve W. Noninflammatory breast carcinoma with skin involvement. Cancer 100 3 (2004) 470-478. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=14745862 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=14745862〉
16. Guth U., Singer G., Schotzau A., Langer I., Dieterich H., Rochlitz C., et al. Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey. Ann Oncol 16 10 (2005) 1618-1623. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16033873 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16033873〉
17. Kwaliteitsinstituut voor de Gezondheitszorg CBO/Vereinigung van Integrale Kankercentra, editors. Lokaal Uitgebreid Mammacarcinoom. In: Richtlijn 'Behandeling van het Mammacarcinoom' Utrecht, 2005. p. 71-82.
18. Rosen P. Invasive duct carcinoma. Assessment of prognosis, morphologic prognostic markers, and tumor growth rate. In: Rosen P. (Ed). Rosen's breast pathology. 2nd ed (2001), Lippincott Williams & Wilkins, Philadelphia 325-364
19. Singletary S.E., and Connolly J.L. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 56 1 (2006) 37-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16449185 [Quiz 50-1. Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16449185〉
20. Wieland A.W., Louwman M.W., Voogd A.C., van Beek M.W., Vreugdenhil G., and Roumen R.M. Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J 10 2 (2004) 123-128. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15009039 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15009039〉
21. Azzopardi J.G., and Eusebi V. Melanocyte colonization and pigmentation of breast carcinoma. Histopathology 1 1 (1977) 21-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=615831 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=615831〉
22. Sau P., Solis J., Lupton G.P., and James W.D. Pigmented breast carcinoma. A clinical and histopathologic simulator of malignant melanoma. Arch Dermatol 125 4 (1989) 536-539. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=2930211 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=2930211〉
23. Guth U., Wight E., Schotzau A., Langer I., Dieterich H., Rochlitz C., et al. Correlation and significance of histopathological and clinical features in breast cancer with skin involvement (T4b). Hum Pathol 37 3 (2006) 264-271. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16613321 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16613321〉
24. Morrow M. Physical examination of the breast. In: Harris J., Lippman M.E., Morrow M., and Osborne C.K. (Eds). Diseases of the breast. 3rd ed (2004), Lippincott Williams & Wilkins, Philadelphia 29-32
25. Speyer J., and Muggia F. Management of locally advanced breast cancer. In: Roses D. (Ed). Breast cancer. 1st ed (1999), Churchill Livingstone, Philadelphia 493-502
26. Rosen P. Unusual clinical presentations of carcinoma. In: Rosen P. (Ed). Rosen's breast pathology. 2nd ed (2001), Lippincott Williams & Wilkins, Philadelphia 653-687
27. Sloane J. Infiltrating carcinoma-pathological types. In: Sloane J. (Ed). Biopsy pathology of the breast. 2nd ed (2001), Arnold, London 170-214
28. Haagensen C. Anatomy of the mammary glands. The lymphatics of the breast diseases of the breast. 3rd ed (1986), W.B. Saunders, Philadelphia p. 25-30
29. Ikomi F., and Schmid-Schonbein G.W. Lymph transport in the skin. Clin Dermatol 13 5 (1995) 419-427. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=8665452 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=8665452〉
30. Skobe M., and Detmar M. Structure, function, and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc 5 1 (2000) 14-19. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=11147669 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=11147669〉
31. Duenne A.A., and Werner J.A. Functional anatomy of lymphatic vessels under the aspect of tumor invasion. Recent Results Cancer Res 157 (2000) 82-89. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=10857163 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=10857163〉
32. Guth U., Wight E., Langer I., Schotzau A., Dieterich H., Herberich L., et al. Breast cancer sagittal/horizontal plane location influences axillary lymph node involvement. Eur J Surg Oncol 32 3 (2006) 287-291. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16466903 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16466903〉
33. Nathanson S.D., Wachna D.L., Gilman D., Karvelis K., Havstad S., and Ferrara J. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 8 10 (2001) 837-843. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=11776500 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=11776500〉
34. Turner-Warwick R. The lymphatics of the breast. BMJ 46 (1957) 574-582
35. Guth U., Wight E., Schotzau A., Langer I., Dieterich H., Rochlitz C., et al. Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification. Cancer 104 9 (2005) 1862-1870. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16130140 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16130140〉
36. Witherspoon L. Discussion on "Management of women who present with T4 breast cancer" by G. V. Poole et al. Am Surg 70 8 (2004) 666-667. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15328797 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15328797〉
37. El-Tamer M., Hussain S., Weedon J., Chalchal H., Chakrabarti A., Sohn C., et al. Prognoses of T4 breast cancer subsets. Ann Surg Oncol 9 4 (2002) 340-345. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=11986185 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=11986185〉
38. Poole G.V., Thigpen J.T., Vance R.B., and Barber W.H. Management of women who present with T4 breast cancer. Am Surg 70 8 (2004) 662-666. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieveamp;&db=PubMed&dop t=Citation&list_uids=15328797 [discussion 66-7. Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15328797〉
39. Price A., Kerr G.R., and Rodger A. Primary radiotherapy for T4 breast cancer. Clin Oncol (R Coll Radiol) 4 4 (1992) 217-221. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=1622883 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=1622883〉
40. Rao D.V., Bedwinek J., Perez C., Lee J., and Fineberg B. Prognostic indicators in stage III and localized stage IV breast cancer. Cancer 50 10 (1982) 2037-2043. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=7127248 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=7127248〉
41. Rubens R.D., Armitage P., Winter P.J., Tong D., and Hayward J.L. Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer 13 8 (1977) 805-811. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=908341 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=908341〉
42. Shen J., Valero V., Buchholz T.A., Singletary S.E., Ames F.C., Ross M.I., et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11 9 (2004) 854-860. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15313733 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15313733〉
43. Sutherland C.M., and Mather F.J. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment). Cancer 55 6 (1985) 1389-1397. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=3971309 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=3971309〉
44. Touboul E., Lefranc J.P., Blondon J., Ozsahin M., Mauban S., Schwartz L.H., et al. Multidisciplinary treatment approach to locally advanced non-inflammatory breast cancer using chemotherapy and radiotherapy with or without surgery. Radiother Oncol 25 3 (1992) 167-175. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=1470693 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=1470693〉
45. Valagussa P., Zambetti M., Bonadonna G., Zucali R., Mezzanotte G., and Veronesi U. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat 15 3 (1990) 137-147. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=2372569 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=2372569〉
46. Yeh K.A., Jillella A.P., and Wei J.P. Surgery for T4 breast carcinoma: implications for local control. Am Surg 66 3 (2000) 250-254. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=10759194 [discussion 55 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=10759194〉
47. Yildirim E., Semerci E., and Berberoglu U. The analysis of prognostic factors in stage III-B non-inflammatory breast cancer. Eur J Surg Oncol 26 1 (2000) 34-38. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=10718177 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=10718177〉
48. Zucali R., and Kenda R. Small size T4 breast cancer. Natural history and prognosis. Tumori 67 3 (1981) 225-230. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=6792758 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=6792758〉
49. Guth U., Wight E., Schotzau A., Langer I., Dieterich H., Rochlitz C., et al. A new approach in breast cancer with non-inflammatory skin involvement. Acta Oncol 45 5 (2006) 576-583. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16864172 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16864172〉
50. Guth U., Singer G., Langer I., Schotzau A., Herberich L., Holzgreve W., et al. T4 category revision enhances the accuracy and significance of stage III breast cancer. Cancer 106 12 (2006) 2569-2575. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16688772 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16688772〉
51. Burke H.B. Outcome prediction and the future of the TNM staging system. J Natl Cancer Inst 96 19 (2004) 1408-1409. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15467022 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15467022〉
52. Barr L.C., and Baum M. Time to abandon TNM staging of breast cancer?. Lancet 339 8798 (1992) 915-917. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=1348309 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=1348309〉
53. Benson J.R., Weaver D.L., Mittra I., and Hayashi M. The TNM staging system and breast cancer. Lancet Oncol 4 1 (2003) 56-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=12517540 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=12517540〉
54. Veronesi U., Viale G., Rotmensz N., and Goldhirsch A. Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. Breast 15 1 (2006) 3-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=16473737 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=16473737〉
55. Cole J., and Kardinal C. Locally advanced and inflammatory breast cancer. In: Donegan W., and Spratt J. (Eds). Cancer of the breast. 5th ed (2002), W.B. Saunders, Philadelphia 579-600
56. Cristofanilli M., Buzdar A.U., and Hortobagyi G.N. Update on the management of inflammatory breast cancer. Oncologist 8 2 (2003) 141-148. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=12697939 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=12697939〉
57. Merajver S., and Sabel M. Inflammatory breast cancer. In: Harris J., Lippman M., Morrow M., and Osborne K. (Eds). Diseases of the breast. 3rd ed (2004), Lippincott Williams & Wilkins, Philadelphia 971-982
58. Hortobagyi G., Singletary S., and Buchholz T. Locally advanced breast cancer. In: Singletary S., Robb G., and Hortobagyi G. (Eds). Advanced therapy of breast disease. 2nd ed (2004), BC Decker, Hamilton 498-508
59. Haagensen C.D. Inflammatory carcinoma. Diseases of the breast. 3rd ed (1986), W.B. Saunders, Philadelphia 808-814
60. Greene F., Page D., Fleming I., Fritz A., Balch C., Haller D., et al., Breast AJCC cancer staging manual. 6th ed (2002), Springer, New York p. 225-6
61. Hance K.W., Anderson W.F., Devesa S.S., Young H.A., and Levine P.H. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97 13 (2005) 966-975. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop t=Citation&list_uids=15998949 Available from 〈http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=15998949〉